Getting to Know NAD+: Why It Drops After 40 and What Actually Restores It
NAD⁺ fuels cellular energy and repair, but what really happens to it after 40? Here's what the research says about exercise, vitamin B3, NR, NMN, and oral NAD⁺.
Read More
NAD⁺ fuels cellular energy and repair, but what really happens to it after 40? Here's what the research says about exercise, vitamin B3, NR, NMN, and oral NAD⁺.
Read More
Your cells are the foundation of everything — energy, immunity, recovery, and aging. This guide breaks down how...
Read More
Cancer-related fatigue affects up to 80% of patients in treatment — and it doesn’t respond to rest. Here’s...
Read More
Not every supplement is your friend during chemo. Here's what the evidence says about which ones carry real interaction risks — and why your oncologist needs...
Read More
40–80% of cancer patients take supplements — but most never tell their doctor. Here's what the research says about which ones are safe, which ones carry...
Read More
Melanoma cases have tripled in the last 30 years and are rising fastest in young people. Here's what you need to know about the types, warning...
Read More
Juice cleanses and detox diets are popular — but during cancer treatment, they can accelerate muscle loss, interfere with medications, and stress the organs your treatment...
Read More
Excess body weight contributes to an estimated 11% of cancers in women and 5% in men — driven by elevated insulin, chronic inflammation, and hormonal dysregulation....
Read More
Tick season is getting more aggressive — and DEET, the go-to repellent for millions, comes with risks most people don’t know about. Here’s what the science...
Read More
Oncology · Groundbreaking Research Largest Peer-Reviewed Study on Off-Label Ivermectin + Mebendazole in Cancer Treatment Published in Anticancer Research Journal The Wellness Company has announced a...
Read More
Bill Gates has called lab-grown meat the future of food. But a growing body of research—on carbon footprints, food safety, and nutrition—suggests the pitch is running...
Read More